ZeptoMetrix PROtrol Respiratory Syncytial Virus Type B (RSV-B)

Description

• Respiratory Syncytial Virus Type B (RSV-B) (Strain: CH93(18)-18) is an enveloped Paramyxovirus that contains a helical nucleocapsid and negative-sense, single-stranded linear RNA
• RSV-B was propagated in Vero cells
• The viral culture fluid was clarified via centrifugation to remove cellular debris prior to inactivation
• PROtrol™ (Protein control) is formulated with viral particles that have been modified to render them non-infectious
• Each vial contains 1.0 mL of RSV-B PROtrol™ frozen in 2% DMEM media
• The pre-inactivation titer was determined from an infectious aliquot
• Each lot of PROtrol™ was tested using an RSV Fusion Protein ELISA
• Viral inactivation is verified by the absence of viral growth in tissue culture-based infectivity assay
• These products are NOT intended for use in the manufacture or processing of injectable products subject to licensure under section 351 of the Public Health Service Act or for any other product intended for administration to humans.